Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and High Dose Chemotherapy
Open Access
- 1 September 2001
- journal article
- review article
- Published by Elsevier in The Journal of Nutrition
- Vol. 131 (9) , 2578S-2584S
Abstract
Glutamine supplementation of enteral and parenteral nutrition support has received increased attention in the research community over the past decade. Glutamine may become a conditionally essential nutrient during certain catabolic states, including after bone marrow transplantation (BMT). The administration of enteral or parenteral glutamine seems safe and also potentially efficacious in some patient groups undergoing intensive treatment for cancer. Studies indicate that adjunctive glutamine treatment may improve nitrogen retention, decrease clinical infection and length of hospital stay and reduce the incidence and severity of mucositis after BMT and high dose chemotherapy. Although not all studies demonstrate benefit, there are sufficient positive data to suggest that this nutrient should be considered in the metabolic support of many individuals undergoing the catabolic process of marrow transplantation. Given the available data, randomized, double-blind, controlled clinical trials of glutamine-enriched nutrition in patients receiving BMT and high dose chemotherapy protocols are indicated to further define the utility of this amino acid as adjunctive therapy. Studies of glutamine nutrition combined with current combinations of cytoreductive agents and hematopoietic growth factors in BMT will be particularly pertinent.Keywords
This publication has 46 references indexed in Scilit:
- Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancerEuropean Journal of Cancer, 1999
- Enteral Glutamine Supplementation for Very‐Low‐Birth‐Weight Infants Decreases Hospital CostsJournal of Parenteral and Enteral Nutrition, 1998
- Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantationBone Marrow Transplantation, 1998
- Parenteral glutamine protects hepatic function during bone marrow transplantationBone Marrow Transplantation, 1998
- Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicityEuropean Journal of Cancer, 1997
- A pilot study of oral glutamine supplementation in patients receiving bone marrow transplantsClinical Nutrition, 1995
- Invited Review: Nutrition Support in Patients With Cancer: What Do the Data Really Show?Nutrition in Clinical Practice, 1994
- Patients Receiving Glutamine‐Supplemented Intravenous Feedings Report an Improvement in MoodJournal of Parenteral and Enteral Nutrition, 1993
- Total Parenteral Nutrition With Glutamine in Bone Marrow Transplantation and Other Clinical Applications (A Randomized, Double‐Blind Study)Journal of Parenteral and Enteral Nutrition, 1993
- Intestinal glutamine metabolism and nutritionThe Journal of Nutritional Biochemistry, 1993